The Demarest Clinic
Pulmonary hypertension stem cell treatment in Thailand typically costs from $35,000 / ฿1,190,000 to $65,000 / ฿2,210,000. The total price depends on the cell type used, the number of injections, and the specific clinic location. In the US, similar procedures cost around $110,000 / ฿3,740,000 on average. Thailand offers savings of around 55%. Programs generally include specialist consultations, cell preparation, and intravenous or localized administration.
Bookimed Expert Insight: Choosing Thailand for cellular therapy provides access to labs accredited by the American Association of Blood Banks (AABB). Clinics like The Demarest Clinic and Longa Heart Health Medical Center emphasize non-invasive cardiovascular revitalization. Patients benefit from specialized facilities including dedicated IV lounges and satellite medical laboratories. Selecting a center led by pioneers like Dr. Ratanapunt Incharoensakdi ensures high-level clinical oversight for complex pulmonary conditions.
| Thailand | Turkey | Austria | |
| Pulmonary hypertension stem cell treatment | from $35,000 / ฿1,190,000 | from $12,000 / ฿408,000 | from $55,000 / ฿1,870,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Pulmonary hypertension stem cell treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pulmonary hypertension stem cell treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pulmonary hypertension stem cell treatment journey.
Dr. Nivit Karla specializes in pulmonary hypertension treatment with extensive training in cardiology and intervention.
Over 41 years of experience in cardiology – Dr. Ratanapunt pioneered non-invasive heart treatments in Thailand, including stem cell therapy for pulmonary hypertension.
Dr. Tatiana Zhelninova-Bosch is a cardiologist and regenerative medicine specialist at The Demarest Clinic in Phuket. She is a recognized leader in stem cell therapy and clinical trial management. Dr. Zhelninova-Bosch previously served as the Chief Physician and Medical Director of Hadassah Medical Moscow. She treats complex conditions like atherosclerosis, heart failure, and pulmonary hypertension.
Stem cell therapy for pulmonary hypertension (PH) in Thailand is an experimental, non-invasive treatment offered mainly at specialised centres in Bangkok and Phuket. It aims to improve pulmonary circulation and exercise capacity, mostly for severe PH cases not responding to standard medication.
Bookimed Expert Insight: Though stem cell therapy appears promising for PH, Thai clinics currently provide it mainly within research or specialised regenerative programmes. Facilities like Longa Heart Health Medical Center and The Demarest Clinic lead with advanced protocols, but no widespread commercial treatments exist yet. This means patients should prioritise centres engaged in clinical research to secure safe, up-to-date care.
Patient Consensus: Stem cell therapy for pulmonary hypertension in Thailand is viewed as an experimental option. Patients advise verifying clinic credentials and prefer treatments only within clinical trials. There’s no solid proof yet that stem cells reliably improve PH symptoms in Thailand.
Stem cell treatment for pulmonary hypertension in Thailand is usually given intravenously at specialised centres. Clinics like The Demarest Clinic in Phuket and Longa Heart Health Medical Center in Bangkok provide allogeneic stem cell therapies approved by Thai health authorities.
Bookimed Expert Insight: The Demarest Clinic in Phuket is unique for ministry authorisation on allogeneic therapies, while Bangkok’s Longa Heart Health Medical Center focuses on holistic cardiac care. Patients tend to choose centres balancing specialised equipment with recognised regulatory approval.
Patient Consensus: Patients say stem cell therapy for pulmonary hypertension in Thailand is mostly experimental. Focus and advice lean towards standard treatments and consulting specialists before pursuing stem cells.
Thailand uses a mix of amniotic fluid stem cells and first-passage umbilical cord mesenchymal stem cells (MSCs) for pulmonary hypertension. These allogeneic cell therapies focus on tissue repair and reversing lung vessel damage. They are offered at specialised clinics like The Demarest Clinic in Phuket.
Bookimed Expert Insight: Most clinics in Thailand combine amniotic fluid and umbilical cord MSCs, as seen at The Demarest Clinic, which supports 1,000+ patients yearly and updates protocols via a global research network. Non-invasive stem cell options also exist, offering less hospital time and recovery stress, ideal for cautious patients.
Patient Consensus: Patients note Thailand’s stem cell treatments focus on repair, with gentle, mostly non-invasive options. Clinics here pair stem cells with oxygen and vitamin therapies, providing hopeful alternatives alongside traditional care pathways.
Stem cell therapy for pulmonary hypertension in Thailand is legal and regulated by the Thai Food and Drug Administration (FDA) and the Ministry of Public Health. Clinics like The Demarest Clinic are officially sanctioned to provide allogeneic stem cell treatments under updated ministry decrees from May 2024.
Bookimed Expert Insight: Clinics like The Demarest Clinic treat 1,000+ patients yearly, showing stem cell therapies are well established in Thailand. Packages often include advanced lab processing onsite, assuring high safety and quality. The Longa Heart Health Medical Center provides specialised cardio care with 5,000+ procedures performed by Dr Ratanapunt Incharoensakdi, a pioneer in non-invasive cardiology.
Patient Consensus: Australian patients report that Thai clinics provide clear official proof of approval. Most stress the importance of checking licences and stem cell certification. Patients appreciate the close supervision by heart specialists in Bangkok and the quality control at Phuket facilities.
Australian patients should ask their doctor about the evidence supporting stem cell therapy for pulmonary hypertension and if it is approved or experimental. They should discuss risks, medication interactions, continuity of care in Australia, and how to assess treatment success with diagnostics like heart catheterisation or echo.
Bookimed Expert Insight: Despite stem cell therapy's appeal, Thailand’s Pulmonary Hypertension clinics lack major clinical trial backing for this treatment. Clinics like The Demarest Clinic in Phuket follow updated protocols, but no Australian doctor endorsements exist. Australian patients should prioritise established therapies and confirm clinic licensing with Thailand’s Ministry of Health.
Patient Consensus: Australians note no credible PH stem cell success stories in Thailand. Many warn it’s largely unproven and stress checking experimental status before travel. Being stable enough to travel for treatment is also a major concern.
Pulmonary hypertension stem cell treatment is not an established or commercially available therapy in Thailand. Clinics advertising it may offer unproven interventions. Australians should rely on approved treatments like vasodilators and consult cardiologists experienced with pulmonary hypertension.
Bookimed Expert Insight: Despite several regenerative medicine clinics in Thailand, none offer validated stem cell treatment specifically for pulmonary hypertension. Most focus on heart disease generally or other chronic conditions. Australians seeking this treatment should prioritise cardiology clinics with proven therapies.
Patient Consensus: Australians report stem cell therapy for pulmonary hypertension is not recognised or available in Thailand. Most recommend consulting Australian specialists for approved heart treatments instead.
Australians pick pulmonary hypertension stem cell treatment clinics in Bangkok by checking doctors' experience, international accreditations, and clinical trial backing. They prioritise clinics with transparent pricing, safe cell processing labs, and clear aftercare, including remote follow-up with Australian cardiologists.
Bookimed Expert Insight: Despite Bangkok having several clinics offering stem cell and non-invasive heart treatments, top doctors like Dr Ratanapunt Incharoensakdi stand out for their extensive experience of 5,000+ procedures and leadership in Thailand’s heart care. Checking a doctor’s specific stem cell experience matters more than clinic volume alone. Also, clinics in Bangkok tend not to disclose TGA-level lab certifications openly, so asking about laboratory standards can reveal trustworthy providers. Remote follow-up options, while rare, are vital given Australia’s distance.
Patient Consensus: Australians report stem cell treatment for pulmonary hypertension lacks proven success in Thailand. They recommend sticking to approved medications and oxygen therapy and consulting Australian specialists before exploring overseas options. Patients note safety and evidence matter most, so they focus on clinics with clear proof of legitimacy and ongoing care plans.